Rehabilitation devices musculoskeletal teams choose should fit clinical goals, safety, durability, and workflow. Learn how to evaluate options wisely and reduce long-term procurement risk.

EU MDR Annex XVI now applies to rehab devices, moving electric wheelchairs and smart walking aids into Class IIa/IIb. See key CE, clinical evaluation, and PMPF impacts.

EFTA sets a new rehab device pre-clearance rule from July 15, requiring 72-hour PCN filing. Learn how CE documents, contracts, and timing may affect EFTA market shipments.

EFTA adds pre-clearance filing for rehab device imports, requiring PCDS 72 hours before departure. Learn the new compliance steps, border risks, and how importers can avoid delays and storage costs.

EU MDR Annex XVI tightens AI rehab device filings from July 9, 2026. Learn new CE rules, ISO/IEC 17025 validation demands, and how to avoid delays in EU market access.

EU MDR Annex XVI now covers AI rehab devices. Learn how the July 9, 2026 rule changes CE filings, ISO/IEC 23053:2026 validation, costs, and market access planning.

EU CE Rule Takes Effect for AI Rehab Devices: learn how MDCG 2026-3 changes CE marking, algorithm validation, and EU export compliance for AI-enabled rehab equipment.

EU Tightens CE Path for AI Rehabilitation Devices: learn how the new MDR Annex XVI update adds third-party validation, extends timelines, raises costs, and reshapes EU market entry plans.